[Remote] Global Health & Market Access Liaison at Danaher Corporation

United States

Danaher Corporation Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Life Sciences, Diagnostics, Biotechnology, HealthcareIndustries

Requirements

  • Advanced Degree: MPH, MS Public Health, PhD degree
  • 5+ years of experience in clinical or translational medicine (hospital, university hospital, teaching hospital)
  • Familiar with international agencies supporting global public health policy and implementation and understanding of global public health in Low- and Middle-income Countries
  • Knowledge in clinical laboratory medicine technologies including genomic medicine, pathology, hematology, and flow cytometry
  • Understanding of global public funding including government and private grant agencies

Responsibilities

  • Coordinate collaborations with academic partners and other outside institutions and support manuscript writing and grant proposals through collaborations with academic partners
  • Participate in professional associations, standardization consortia, and advocacy organizations
  • Anticipate and evaluate market drivers, including regulatory and reimbursement policies as well as changing practice guidelines
  • Ensure compliance with internal and external policies, guidelines, and regulations
  • Present data on product performance or other relevant materials at national and international meetings to increase portfolio visibility through external key experts
  • Perform Market Access Research on new and emerging technologies and support global market access with reimbursement processes including CPT coding and other methods for health reimbursement payment
  • Serve as the principal interface between the business and stakeholders in the global scientific community, including key experts and customers in clinical and research laboratories, professional societies, government agencies, Non-Governmental Organizations (NGO), Ministry of Health, Global Funders, Implementing Partners, Health Policy Organizations, advocacy groups, and other customers/market influencers
  • Support a broad range of internal cross-functional activities, working closely with marketing, sales, research & development, clinical affairs, and regulatory affairs

Skills

Medical Affairs
Scientific Affairs
Stakeholder Engagement
Health Policy
Global Health
Laboratory Science
Clinical Research
Advocacy
NGO Relations
Government Affairs

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters
1969Year Founded
IPOCompany Stage
Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries
10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.
Potential regulatory challenges in the EU for water quality sector.
Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.
The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.
Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.
Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.
Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI